Andrew R. Allen files SEC Form 4 disclosures for Clovis Oncology, Inc.. They have made 4 open-market trades across 3 companies since 2011, most recently 2024-06-24.
CIK 0001374539
2 open-market purchases totalling $158K since 2011, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GRTS | SELL | 2024-05-16 | 2024-05-17 | $0.75 | $18K | -5.6% | -3.7% | -32.9% |
| SRRA | BUY | 2018-12-10 | 2018-12-11 | $1.64 | $108K | -26.8% | -9.8% | +20.3% |
| CLVS | SELL · 10b5-1 | 2015-01-16 | 2015-01-20 | $65.88 | $3.2M | -29.4% | -2.5% | -2.5% |
| CLVS | SELL · 10b5-1 | 2015-01-15 | 2015-01-21 | $65.88 | $5.3M | -29.4% | -2.5% | -2.5% |
| CLVS | SELL | 2013-06-05 | 2013-06-07 | $68.54 | $1.5M | -29.4% | -2.5% | -2.5% |
| CLVS | BUY | 2011-11-21 | 2011-11-21 | $13.00 | $50K | -29.4% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.